Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lale Umutlu

Showing results (291-300 of 315) with videos related to

Pageof 32
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2024
Impact of <sup>18</sup>F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center TrialKai Jannusch, Lale Umutlu, Julian Kirchner, et al.
European Heart Journal|August 14, 2021
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapyLars Michel, Iris Helfrich, Ulrike Barbara Hendgen-Cotta, et al.
Theranostics|September 23, 2024
Theranostics with somatostatin receptor antagonists in SCLC: Correlation of <sup>68</sup>Ga-SSO120 PET with immunohistochemistry and survivalIlektra Antonia Mavroeidi, Anna Romanowicz, Tristan Haake, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2022
Optimized Whole-Body PET MRI Sequence Workflow in Pediatric Hodgkin Lymphoma PatientsThomas W Georgi, Dietrich Stoevesandt, Lars Kurch, et al.
The Lancet. Oncology|August 1, 2024
Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective studyMadeleine J Karpinski, Johannes Hüsing, Kevin Claassen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 25, 2023
<sup>68</sup>Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective StudyRiccardo Mei, Lukas Kessler, Kim M Pabst, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 31, 2019
Clinical impact of PET/MR in treated colorectal cancer patientsBarbara J Amorim, Theodore S Hong, Lawrence S Blaszkowsky, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2022
Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on <sup>18</sup>F-FDG PET/MRI and Machine LearningJanna Morawitz, Benjamin Sigl, Christian Rubbert, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 9, 2020
Improving staging of rectal cancer in the pelvis: the role of PET/MRIOnofrio A Catalano, Susanna I Lee, Chiara Parente, et al.
Breast Cancer Research : BCR|March 19, 2021
Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrialsMonika Graeser, Simone Schrading, Oleg Gluz, et al.
Pageof 32

Showing results (291-300 of 315) with videos related to

Sort By:
Pageof 32
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2024
Impact of <sup>18</sup>F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center TrialKai Jannusch, Lale Umutlu, Julian Kirchner, et al.
European Heart Journal|August 14, 2021
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapyLars Michel, Iris Helfrich, Ulrike Barbara Hendgen-Cotta, et al.
Theranostics|September 23, 2024
Theranostics with somatostatin receptor antagonists in SCLC: Correlation of <sup>68</sup>Ga-SSO120 PET with immunohistochemistry and survivalIlektra Antonia Mavroeidi, Anna Romanowicz, Tristan Haake, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2022
Optimized Whole-Body PET MRI Sequence Workflow in Pediatric Hodgkin Lymphoma PatientsThomas W Georgi, Dietrich Stoevesandt, Lars Kurch, et al.
The Lancet. Oncology|August 1, 2024
Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective studyMadeleine J Karpinski, Johannes Hüsing, Kevin Claassen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 25, 2023
<sup>68</sup>Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective StudyRiccardo Mei, Lukas Kessler, Kim M Pabst, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 31, 2019
Clinical impact of PET/MR in treated colorectal cancer patientsBarbara J Amorim, Theodore S Hong, Lawrence S Blaszkowsky, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2022
Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on <sup>18</sup>F-FDG PET/MRI and Machine LearningJanna Morawitz, Benjamin Sigl, Christian Rubbert, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 9, 2020
Improving staging of rectal cancer in the pelvis: the role of PET/MRIOnofrio A Catalano, Susanna I Lee, Chiara Parente, et al.
Breast Cancer Research : BCR|March 19, 2021
Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrialsMonika Graeser, Simone Schrading, Oleg Gluz, et al.
Pageof 32